Efficacy and safety of hepatic arterial infusion chemotherapy combined with lenvatinib and sequential ablation in the treatment of advanced hepatocellular carcinoma-Reference-Cited by-同舟云学术

Efficacy and safety of hepatic arterial infusion chemotherapy combined with lenvatinib and sequential ablation in the treatment of advanced hepatocellular carcinoma

Published:2022-10-17 Issue:5 Volume:12 Page:5436-5449
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Medicine

Author:

Liu Yulong¹,Qiao Yansong²,Zhou Miaoli³,Guo Jiandong¹,Lin Yinsheng¹,Li Wanghai¹,An Chao⁴,Li Chengzhi¹^ORCID

Affiliation:

1. Department of Interventional Radiology and Vascular Surgery The First Affiliated Hospital of Jinan University Guangzhou China

2. Department of Radiology Baoji Hospital Affiliated to Xi'an Medical College Baoji China

3. Department of Nuclear Medicine The First Affiliated Hospital of Jinan University Guangzhou China

4. Department of Minimal Invasive Intervention Sun Yat‐sen University Cancer Center Guangzhou China

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.5366

Reference36 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

2. Hepatocellular carcinoma

3. Hepatocellular carcinoma (HCC): Epidemiology, etiology and molecular classification

4. Hepatocellular carcinoma

5. Treatment of Hepatocellular Carcinoma in the Precision Medicine Era: From Treatment Stage Migration to Therapeutic Hierarchy

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of hepatic arterial infusion chemotherapy and its combination strategies for advanced hepatocellular carcinoma: A network meta-analysis;World Journal of Gastrointestinal Oncology;2024-08-15

2. Hepatic Artery Infusion Chemotherapy for Primary and Secondary Malignancies of the Liver: State of the Art and Current High-Level Evidence;Pharmacology;2024

3. The worthy role of hepatic arterial infusion chemotherapy in combination with anti-programmed cell death protein 1 monoclonal antibody immunotherapy in advanced hepatocellular carcinoma;Frontiers in Immunology;2023-10-31

4. Antineoplastics;Reactions Weekly;2023-09-09